Published in J Neuroimmunol on July 02, 2007
Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol (2012) 1.37
Studies in the modulation of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (2010) 0.95
Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine (2010) 0.91
Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection. Future Virol (2008) 0.90
Potential triggers of MS. Results Probl Cell Differ (2010) 0.87
Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis. Brain Behav Immun (2014) 0.83
CMV infection attenuates the disease course in a murine model of multiple sclerosis. PLoS One (2012) 0.79
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis. J Neurovirol (2012) 0.75
Unresolved issues in theories of autoimmune disease using myocarditis as a framework. J Theor Biol (2014) 0.75
Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol (1999) 9.55
Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron (1994) 5.50
Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A (1993) 5.00
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science (1985) 3.68
Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature (1975) 3.49
No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol (2002) 3.20
Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol (2004) 2.84
The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods (1998) 2.78
IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med (1996) 2.69
Initial and innate responses to viral infections--pattern setting in immunity or disease. Curr Opin Microbiol (1999) 2.08
Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol (2003) 2.05
Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol (1989) 1.85
Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol (2003) 1.76
The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J Virol (2001) 1.75
Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol (1995) 1.48
Evasion of innate immunity by vaccinia virus. Parasitology (2005) 1.42
Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol (1998) 1.39
Axonal injury heralds virus-induced demyelination. Am J Pathol (2003) 1.38
Epstein-Barr virus in pediatric multiple sclerosis. JAMA (2004) 1.38
Is IgG2a a good Th1 marker in mice? Immunol Today (1998) 1.26
The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes. Immunogenetics (1989) 1.24
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol (2001) 1.21
Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol (2000) 1.17
A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination. Proc Natl Acad Sci U S A (1992) 1.12
Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol (1998) 1.11
Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J Neuropathol Exp Neurol (1997) 1.09
Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. Arch Virol (1995) 1.08
Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires. J Immunol (2005) 1.06
Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol (1999) 1.04
Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity (2006) 1.04
Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons. Am J Pathol (2002) 1.03
Viruses can silently prime for and trigger central nervous system autoimmune disease. J Neurovirol (2001) 1.03
Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. Crit Rev Immunol (2004) 0.98
Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity. J Virol (2002) 0.97
Functional activation of myelin-specific T cells by virus-induced molecular mimicry. J Immunol (2002) 0.96
Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J Neuroimmunol (2000) 0.96
Infection of mice with lactic dehydrogenase virus prevents development of experimental allergic encephalomyelitis. J Neuroimmunol (1986) 0.94
Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1993) 0.94
Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am J Pathol (2005) 0.94
Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial? Am J Pathol (2007) 0.92
Murine cytomegalovirus infection: hematological, morphological, and functional study of lymphoid cells. Infect Immun (1981) 0.92
The Th1/Th2 balance does not account for the difference of susceptibility of mouse strains to Theiler's virus persistent infection. J Immunol (1999) 0.89
Disparate expression of IL-12 by SJL/J and B10.S macrophages during Theiler's virus infection is associated with activity of TLR7 and mitogen-activated protein kinases. Microbes Infect (2005) 0.88
Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Eur J Immunol (1997) 0.88
Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. J Neuroimmunol (2004) 0.87
Vaccinia virus meningitis in mice after intracerebral inoculation. Infect Immun (1976) 0.85
Induction of apoptosis of T cells by infecting mice with murine cytomegalovirus. J Virol (1995) 0.85
Virus-mediated autoimmunity in Multiple Sclerosis. J Autoimmune Dis (2006) 0.85
The case for rhinoviruses in the pathogenesis of multiple sclerosis. Mult Scler (2005) 0.83
Antigen-presenting cell activation: a link between infection and autoimmunity? J Autoimmun (2001) 0.82
Experimental vaccinia virus meningoencephalitis in adult albino mice: virological, light microscopic and ultrastructural studies. Acta Neuropathol (1977) 0.82
Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1997) 0.82
Light and electron microscopic studies of the pathogenesis of vaccinia virus infection in mouse brain. Proc Soc Exp Biol Med (1982) 0.82
Virus-induced polyclonal T cell activation is followed by apoptosis: partitioning of CD8+ T cells based on alpha 4 integrin expression. Int Immunol (1996) 0.81
Cytokines in the pathogenesis and therapy of autoimmune encephalomyelitis and multiple sclerosis. Adv Exp Med Biol (2003) 0.81
Neurovirulence of vaccinia viruses for mice. Zentralbl Bakteriol Orig A (1974) 0.80
Pediatric multiple sclerosis. Curr Neurol Neurosci Rep (2004) 0.80
Polymicrobial infection and the eye. Br J Ophthalmol (2006) 0.80
Effect of antithymocyte serum of murine cytomegalovirus emcephalitis in weanling mice. Rev Can Biol (1975) 0.79
Two-step activation of T cells, clonal expansion and subsequent Th1 cytokine production, is essential for the development of clinical autoimmune encephalomyelitis. Eur J Immunol (2001) 0.78
Communicating hydrocephalus in newborn hamsters and cats following vaccinia virus infection. J Neurosurg (1981) 0.77
Memory T cells: total recall or just a sense of déjà vu? Nat Immunol (2001) 0.76
Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol (2003) 1.76
Axonal injury heralds virus-induced demyelination. Am J Pathol (2003) 1.38
Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol (2012) 1.37
Autistic disorder and viral infections. J Neurovirol (2005) 1.33
Seizures following picornavirus infection. Epilepsia (2008) 1.31
Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia (2009) 1.26
Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination. Springer Semin Immunopathol (2002) 1.24
Pathogenic epitopes, heterologous immunity and vaccine design. Nat Rev Microbiol (2007) 1.24
Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol (2011) 1.22
Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol (2006) 1.16
Development of postinfection epilepsy after Theiler's virus infection of C57BL/6 mice. J Neuropathol Exp Neurol (2010) 1.14
Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. Mult Scler (2004) 1.08
Theiler's virus infection chronically alters seizure susceptibility. Epilepsia (2009) 1.05
Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity (2006) 1.04
Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol (2007) 1.03
Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis. J Neuroimmune Pharmacol (2009) 1.01
T cell infiltration is associated with increased Lyme arthritis in TLR2-/- mice. FEMS Immunol Med Microbiol (2007) 1.01
Molecular mimicry in multiple sclerosis. Int Rev Neurobiol (2007) 0.98
Infiltrating macrophages are key to the development of seizures following virus infection. J Virol (2012) 0.98
Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity. J Virol (2002) 0.97
Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infection. J Virol (2005) 0.96
The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis. J Neuroimmunol (2006) 0.96
Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice. NMR Biomed (2014) 0.96
Studies in the modulation of experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (2010) 0.95
Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am J Pathol (2005) 0.94
Role for complement in the development of seizures following acute viral infection. J Virol (2010) 0.94
Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial? Am J Pathol (2007) 0.92
Role of CD5+ B-1 cells in EAE pathogenesis. Autoimmunity (2008) 0.92
TGF-beta1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus. J Neuroimmunol (2007) 0.91
Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines. Vaccine (2010) 0.91
Once initiated, viral encephalitis-induced seizures are consistent no matter the treatment or lack of interleukin-6. J Neurovirol (2011) 0.91
Hyperserotoninemia and altered immunity in autism. J Autism Dev Disord (2006) 0.90
Multiple sclerosis: autoimmunity and viruses. Curr Opin Rheumatol (2013) 0.89
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade. Brain Pathol (2007) 0.89
Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. J Neuroimmunol (2004) 0.87
Regulatory role of CD1d in neurotropic virus infection. J Virol (2008) 0.87
Potential triggers of MS. Results Probl Cell Differ (2010) 0.87
IFN-gamma production and astrocyte recognition by autoreactive T cells induced by Theiler's virus infection: role of viral strains and capsid proteins. J Neuroimmunol (2005) 0.87
Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen. J Neuroimmunol (2012) 0.86
Investigation of treatment failure in neonatal echovirus 7 infection. Pediatr Infect Dis J (2006) 0.86
Are there enhanced MBP autoantibodies in autism? J Autism Dev Disord (2007) 0.86
Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus. Future Virol (2011) 0.85
Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection. J Virol (2011) 0.83
How relevant are GFAP autoantibodies in autism and Tourette Syndrome? J Autism Dev Disord (2007) 0.83
Role of pathogens in multiple sclerosis. Int Rev Immunol (2013) 0.82
Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: a mechanism for the failure of persistence by the mutant virus. J Neurovirol (2002) 0.82
Modulation of immune system function by measles virus infection. II. Infection of B cells leads to the production of a soluble factor that arrests uninfected B cells in G0/G1. Viral Immunol (2003) 0.82
Monoclonal MOG-reactive autoantibody from progressive EAE has the characteristics of a natural antibody. J Neuroimmunol (2006) 0.81
Role for antibodies in altering behavior and movement. Autism Res (2010) 0.81
Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis. J Neuroimmunol (2008) 0.80
Neurons tame T cells. Nat Med (2006) 0.79
Antiviral CD8⁺ T cells cause an experimental autoimmune encephalomyelitis-like disease in naive mice. J Neurovirol (2012) 0.79
Infectious RNA isolated from the spinal cords of mice chronically infected with Theiler's murine encephalomyelitis virus. J Virol (2006) 0.79
Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding. J Neurovirol (2008) 0.79
Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis. J Neuroimmunol (2007) 0.79
The activity within the CA3 excitatory network during Theiler's virus encephalitis is distinct from that observed during chronic epilepsy. J Neurovirol (2012) 0.78
Discovery of biologically active oncologic and immunologic small molecule therapies using zebrafish: overview and example of modulation of T cell activation. Curr Protoc Pharmacol (2013) 0.78
Manganese superoxide dismutase induction during measles virus infection. J Med Virol (2003) 0.78
Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis. J Neurovirol (2008) 0.78
Cross-reactive myelin antibody induces renal pathology. Autoimmunity (2008) 0.77
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis. Autoimmunity (2014) 0.77
In vitro antigen-specific induction of IL-22 in human subjects that resolved HCV infection. Future Virol (2012) 0.76
A potential link between measles virus and autism: age-matched control groups are essential. Pediatr Neurol (2004) 0.75
Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease. J Neurovirol (2012) 0.75
Axonal pathology and demyelination in viral models of multiple sclerosis. Discov Med (2014) 0.75
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis. J Neurovirol (2012) 0.75
Letting antibodies get to your head. Nat Med (2003) 0.75
Role of B:T cell ratio in suppression of clinical signs: a model for silent MS. Exp Mol Pathol (2008) 0.75
Are there altered antibody responses to measles, mumps, or rubella viruses in autism? J Neurovirol (2007) 0.75
Altered cell growth and morphology in a BHK-21 cell mutant that lacks a receptor for Theiler's murine encephalomyelitis virus. Virology (2002) 0.75